The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Svennberg E et al. Transforming Atrial Fibrillation Management by Targeting Comorbidities and Reducing Atrial Fibrillation Burden: the 10th AFNET/EHRA Consensus Conference. Europace, 15 Dec 2025. DOI: ...

Key takeawaysAn international panel of more than 80 experts has issued updated guidance to improve care for atrial fibrillation (AF) patients ...

Dr Emma Svennberg, cardiologist in Stockholm and first author of the consensus paper, noted that modern AF care requires a more streamlined and holistic approach. She highlighted the need to address ...